MedTrace Logo

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

NCT00745433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 906

Last updated 2023-11-02

No results posted yet for this study

Summary

This study is conducted in Europe. The aim of this observational study is to investigate the efficacy (e.g. glycemic control) and safety (e.g. hypoglycemic episodes) when adding repaglinide to a monotherapy of metformin in type 2 diabetic patients under normal clinical practice

Conditions

Interventions

DRUG

repaglinide

Start dose and frequency at the discretion of the physician following clinical practice

DRUG

metformin

Start dose and frequency at the discretion of the physician following clinical practice

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00745433 on ClinicalTrials.gov